HLA-DRS100A

Ren-Qi Yao1,2,3, Peng-Yue Zhao1,4, Zhi-Xuan Li1

  • 1Translational Medicine Research Center, Medical Innovation Research Division and the Fourth Medical Center of Chinese PLA General Hospital, Beijing, 100853, China.

PubMed
概括

研究人员确定了一种新的单细胞子集,HLA-DR低S100A高,与败血症诱导的免疫抑制有关. 用Paquinimod阻断S100A9部分逆转了免疫抑郁症,为败血症管理提供了一个新的治疗策略.